Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,057 hedge funds and large institutions have $96.3B invested in Allergan plc in 2015 Q3 according to their latest regulatory filings, with 120 funds opening new positions, 403 increasing their positions, 408 reducing their positions, and 92 closing their positions.
30% more first-time investments, than exits
New positions opened: 120 | Existing positions closed: 92
15% more call options, than puts
Call options by funds: $1.73B | Put options by funds: $1.51B
2% more funds holding
Funds holding: 1,036 → 1,057 (+21)
1% less repeat investments, than reductions
Existing positions increased: 403 | Existing positions reduced: 408
7% less capital invested
Capital invested by funds: $104B → $96.3B (-$7.27B)
11% less funds holding in top 10
Funds holding in top 10: 176 → 157 (-19)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$1.01B |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$963M |
| 3 |
JP Morgan Chase
New York
|
+$751M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$541M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$448M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.45B |
| 2 |
Jennison Associates
New York
|
-$297M |
| 3 |
SCM
Steadfast Capital Management
New York
|
-$283M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$270M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$253M |
AGN Hedge Fund Activity: Q3 2015 in Review
1,057 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2015, worth a combined $96.3B — down 7% from $104B a quarter earlier.
Buyers outnumbered sellers: 120 funds opened new AGN positions and 92 closed out — a net gain of 28 holders — while 403 added to existing stakes and 408 trimmed.
The largest buyer was Norges Bank, opening a new position worth an estimated $1.01B. The largest seller was Fidelity Investments, cutting an estimated $1.45B.
- 1,057 institutional investors held Allergan plc (AGN) as of Q3 2015, up from 1,036 in Q2 2015.
- Funds reported $96.3B of Allergan plc stock for Q3 2015, down 7% quarter-over-quarter.
- 120 funds opened new Allergan plc positions in Q3 2015 and 92 closed out, a net change of +28 holders.
- The largest Allergan plc buyer in Q3 2015 was Norges Bank, an estimated $1.01B added.
- The largest Allergan plc seller in Q3 2015 was Fidelity Investments, an estimated $1.45B sold.
Based on aggregated 13F filings for Q3 2015.